Table: Noile-Immune Biotech -2024 parent results
Feb 14 (Reuters)-
Noile-Immune Biotech Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2024 Dec 31, 2023 Dec 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 7 mln 316 mln
(-97.6 pct) (-49.3 pct)
Operating loss 1.07 loss 775 mln
Recurring loss 962 mln loss 1.13
Net loss 964 mln loss 1.13
EPS loss 22.28 yen loss 27.25 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Noile-Immune Biotech Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T